UniProt ID | CSR2B_HUMAN | |
---|---|---|
UniProt AC | Q9H8E8 | |
Protein Name | Cysteine-rich protein 2-binding protein | |
Gene Name | KAT14 {ECO:0000312|HGNC:HGNC:15904} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 782 | |
Subcellular Localization | Nucleus. Cytoplasm. Mainly nuclear. | |
Protein Description | Component of the ATAC complex, a complex with histone acetyltransferase activity on histones H3 and H4. May function as a scaffold for the ATAC complex to promote ATAC complex stability. Has also weak histone acetyltransferase activity toward histone H4. Required for the normal progression through G1 and G2/M phases of the cell cycle.. | |
Protein Sequence | MDSSIHLSSLISRHDDEATRTSTSEGLEEGEVEGETLLIVESEDQASVDLSHDQSGDSLNSDEGDVSWMEEQLSYFCDKCQKWIPASQLREQLSYLKGDNFFRFTCSDCSADGKEQYERLKLTWQQVVMLAMYNLSLEGSGRQGYFRWKEDICAFIEKHWTFLLGNRKKTSTWWSTVAGCLSVGSPMYFRSGAQEFGEPGWWKLVHNKPPTMKPEGEKLSASTLKIKAASKPTLDPIITVEGLRKRASRNPVESAMELKEKRSRTQEAKDIRRAQKEAAGFLDRSTSSTPVKFISRGRRPDVILEKGEVIDFSSLSSSDRTPLTSPSPSPSLDFSAPGTPASHSATPSLLSEADLIPDVMPPQALFHDDDEMEGDGVIDPGMEYVPPPAGSVASGPVVGVRKKVRGPEQIKQEVESEEEKPDRMDIDSEDTDSNTSLQTRAREKRKPQLEKDTKPKEPRYTPVSIYEEKLLLKRLEACPGAVAMTPEARRLKRKLIVRQAKRDRGLPLFDLDQVVNAALLLVDGIYGAKEGGISRLPAGQATYRTTCQDFRILDRYQTSLPSRKGFRHQTTKFLYRLVGSEDMAVDQSIVSPYTSRILKPYIRRDYETKPPKLQLLSQIRSHLHRSDPHWTPEPDAPLDYCYVRPNHIPTINSMCQEFFWPGIDLSECLQYPDFSVVVLYKKVIIAFGFMVPDVKYNEAYISFLFVHPEWRRAGIATFMIYHLIQTCMGKDVTLHVSASNPAMLLYQKFGFKTEEYVLDFYDKYYPLESTECKHAFFLRLRR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MDSSIHLSSL -----CCCCEEHHHH | 29.87 | 23186163 | |
4 | Phosphorylation | ----MDSSIHLSSLI ----CCCCEEHHHHH | 15.12 | 27174698 | |
8 | Phosphorylation | MDSSIHLSSLISRHD CCCCEEHHHHHHHCC | 14.67 | 27174698 | |
9 | Phosphorylation | DSSIHLSSLISRHDD CCCEEHHHHHHHCCC | 35.76 | 27174698 | |
12 | Phosphorylation | IHLSSLISRHDDEAT EEHHHHHHHCCCCCC | 28.93 | 27174698 | |
19 | Phosphorylation | SRHDDEATRTSTSEG HHCCCCCCCCCCCCC | 32.22 | 27174698 | |
97 | Ubiquitination | REQLSYLKGDNFFRF HHHHHHHCCCCEEEE | 56.86 | - | |
105 | Phosphorylation | GDNFFRFTCSDCSAD CCCEEEEEECCCCCC | 13.57 | 29052541 | |
107 | Phosphorylation | NFFRFTCSDCSADGK CEEEEEECCCCCCCH | 38.30 | 29052541 | |
110 | Phosphorylation | RFTCSDCSADGKEQY EEEECCCCCCCHHHH | 34.09 | 29052541 | |
117 | Phosphorylation | SADGKEQYERLKLTW CCCCHHHHHHHCCHH | 12.24 | - | |
123 | Phosphorylation | QYERLKLTWQQVVML HHHHHCCHHHHHHHH | 21.46 | - | |
185 | Phosphorylation | AGCLSVGSPMYFRSG HHHCCCCCCEEECCC | 12.35 | 28555341 | |
218 | "N6,N6-dimethyllysine" | TMKPEGEKLSASTLK CCCCCCCCCCHHHEE | 59.61 | - | |
218 | Methylation | TMKPEGEKLSASTLK CCCCCCCCCCHHHEE | 59.61 | - | |
220 | Phosphorylation | KPEGEKLSASTLKIK CCCCCCCCHHHEEEE | 31.10 | 23312004 | |
222 | Phosphorylation | EGEKLSASTLKIKAA CCCCCCHHHEEEEEC | 30.78 | 23312004 | |
223 | Phosphorylation | GEKLSASTLKIKAAS CCCCCHHHEEEEECC | 31.61 | 23312004 | |
231 | Acetylation | LKIKAASKPTLDPII EEEEECCCCCCCCEE | 36.98 | 26051181 | |
248 | Phosphorylation | EGLRKRASRNPVESA HHHHHHHHCCHHHHH | 36.30 | 28555341 | |
265 | Phosphorylation | LKEKRSRTQEAKDIR HHHHHHHHHHHHHHH | 31.82 | 25106551 | |
269 | Acetylation | RSRTQEAKDIRRAQK HHHHHHHHHHHHHHH | 53.59 | 23749302 | |
276 | Acetylation | KDIRRAQKEAAGFLD HHHHHHHHHHCCCCC | 48.62 | 25953088 | |
285 | Phosphorylation | AAGFLDRSTSSTPVK HCCCCCCCCCCCCEE | 32.10 | 25159151 | |
286 | Phosphorylation | AGFLDRSTSSTPVKF CCCCCCCCCCCCEEE | 27.82 | 28450419 | |
287 | Phosphorylation | GFLDRSTSSTPVKFI CCCCCCCCCCCEEEC | 33.20 | 28450419 | |
288 | Phosphorylation | FLDRSTSSTPVKFIS CCCCCCCCCCEEECC | 36.50 | 28450419 | |
289 | Phosphorylation | LDRSTSSTPVKFISR CCCCCCCCCEEECCC | 31.69 | 25159151 | |
292 | Acetylation | STSSTPVKFISRGRR CCCCCCEEECCCCCC | 37.88 | 19608861 | |
295 | Phosphorylation | STPVKFISRGRRPDV CCCEEECCCCCCCCE | 31.64 | 23312004 | |
324 | Phosphorylation | SSDRTPLTSPSPSPS CCCCCCCCCCCCCCC | 39.53 | 26074081 | |
325 | Phosphorylation | SDRTPLTSPSPSPSL CCCCCCCCCCCCCCC | 30.94 | 26074081 | |
327 | Phosphorylation | RTPLTSPSPSPSLDF CCCCCCCCCCCCCCC | 37.46 | 26074081 | |
329 | Phosphorylation | PLTSPSPSPSLDFSA CCCCCCCCCCCCCCC | 31.30 | 26074081 | |
335 | Phosphorylation | PSPSLDFSAPGTPAS CCCCCCCCCCCCCCC | 32.97 | 26074081 | |
339 | Phosphorylation | LDFSAPGTPASHSAT CCCCCCCCCCCCCCC | 18.02 | 26074081 | |
342 | Phosphorylation | SAPGTPASHSATPSL CCCCCCCCCCCCHHH | 21.12 | 26074081 | |
344 | Phosphorylation | PGTPASHSATPSLLS CCCCCCCCCCHHHHC | 31.20 | 26074081 | |
394 | Phosphorylation | PPAGSVASGPVVGVR CCCCCCCCCCEEEEE | 41.28 | - | |
416 | Phosphorylation | QIKQEVESEEEKPDR HHHHHHHCCCCCCCC | 56.32 | 23401153 | |
428 | Phosphorylation | PDRMDIDSEDTDSNT CCCCCCCCCCCCCCH | 37.39 | 23663014 | |
431 | Phosphorylation | MDIDSEDTDSNTSLQ CCCCCCCCCCCHHHH | 36.96 | 23663014 | |
433 | Phosphorylation | IDSEDTDSNTSLQTR CCCCCCCCCHHHHHH | 44.06 | 23663014 | |
435 | Phosphorylation | SEDTDSNTSLQTRAR CCCCCCCHHHHHHHH | 34.46 | 27732954 | |
436 | Phosphorylation | EDTDSNTSLQTRARE CCCCCCHHHHHHHHH | 23.80 | 25849741 | |
439 | Phosphorylation | DSNTSLQTRAREKRK CCCHHHHHHHHHHCC | 31.43 | 18669648 | |
444 | Acetylation | LQTRAREKRKPQLEK HHHHHHHHCCCCCCC | 61.23 | - | |
461 | Phosphorylation | KPKEPRYTPVSIYEE CCCCCCCCCCCHHHH | 20.63 | 21815630 | |
485 | Phosphorylation | CPGAVAMTPEARRLK CCCCCCCCHHHHHHH | 14.29 | 28450419 | |
526 | Phosphorylation | LLLVDGIYGAKEGGI HHHHHHCCCCCCCCC | 19.29 | - | |
572 | Acetylation | GFRHQTTKFLYRLVG CCCHHHHHHHHHHHC | 36.44 | 23954790 | |
599 | Ubiquitination | PYTSRILKPYIRRDY HHHHHCCHHHHCCCC | 33.14 | - | |
606 | Phosphorylation | KPYIRRDYETKPPKL HHHHCCCCCCCCCHH | 24.56 | 25002506 | |
608 | Phosphorylation | YIRRDYETKPPKLQL HHCCCCCCCCCHHHH | 42.49 | 25002506 | |
717 | Phosphorylation | WRRAGIATFMIYHLI HHHHHHHHHHHHHHH | 16.30 | 23401153 | |
721 | Phosphorylation | GIATFMIYHLIQTCM HHHHHHHHHHHHHHC | 4.45 | 23401153 | |
726 | Phosphorylation | MIYHLIQTCMGKDVT HHHHHHHHHCCCCEE | 9.47 | 23401153 | |
763 | Acetylation | YVLDFYDKYYPLEST EEHHHHHHHCCCCCC | 34.99 | 26051181 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CSR2B_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CSR2B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CSR2B_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MBIP1_HUMAN | MBIP | physical | 19060904 | |
H31_HUMAN | HIST1H3A | physical | 19103755 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-292 AND LYS-572, AND MASSSPECTROMETRY. |